Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VANTAGE: Volixibat in Primary Biliary Cholangitis
NCT05050136Phase 2Active, not recruiting
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Sep 2021
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of volixibat in primary biliary cholangitis (PBC), sponsored by Mirum Pharmaceuticals, Inc.. Started Sep 2021; status: active, not recruiting.
02
Drugs
volixibat
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT05050136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05050136.